The Centers for Disease Control and Prevention in Malawi is offering a grant to support the Ministry of Health in scaling up high-quality laboratory services for HIV diagnosis, care, treatment, and monitoring. With a focus on strengthening laboratory management and accreditation, this program aims to enhance the country’s capacity to deliver on national health priorities, including increasing CD4 cut-offs and implementing viral load monitoring. Through the President’s Emergency Plan for AIDS Relief (PEPFAR), CDC-Malawi has a history of building laboratory capacity, implementing quality control systems, and improving testing quality across referral, central, and district laboratories. The grant aims to further enhance laboratory services to ensure effective HIV screening, diagnosis, and treatment monitoring in Malawi.
Opportunity ID: 286889
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH15-15510201SUPP16 |
| Funding Opportunity Title: | Program Expansion Supplement: Strengthening High Quality Laboratory Services Scale-up for HIV Diagnosis, Care, Treatment and Monitoring in Malawi under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.067 — Global AIDS |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 02, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 01, 2016 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Oct 01, 2016 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Oct 31, 2016 |
| Estimated Total Program Funding: | $1,345,600 |
| Award Ceiling: | $1,345,600 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible entities for this announcement are listed below: Univerity Research Co. LLC |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | In 2012, Malawi reported a 10.8% prevalence rate in adults 15 years old or older and an incidence rate of 0.76% in the age group between 15 to 49 years old. Over 1,700,000 people got HIV counseling and testing services in that year. Also in 2012, more people were started on anti-retroviral treatment than the number of newly infected people, 114,120 and 66,000, respectively. Malawi has therefore reached the tipping point, but more needs to be done in prevention, diagnosis, determining eligibility, and monitoring patients on anti-retroviral therapy (ART). The Ministry of Health (MOH) has embarked on a number of policies for the prevention of HIV infection, including Voluntary Medical Male Circumcision (VMMC) and Option B+ Prevention of Mother To Child Transmission (PMTCT). Malawi has also scaled up an ambitious anti-retroviral treatment program for adults and children. By end of the third quarter of 2013, a total of 459,261 were alive on treatment, representing coverage among children (under 15) and adults of 47% and 81%, respectively. Additionally, with the assistance of partners, the MOH has increased point of care sites for HIV diagnosis and CD4 count, malaria and tuberculosis microscopy sites, hematology, and chemistry at district level and molecular work for HIV and diagnosis and monitoring in referral hospitals. However, improving on and maintaining a reliable and quality assured system of medical laboratories is necessary to ensure adequate screening, diagnosis, opportunistic diseases diagnosis, eligibility determination, and monitoring for only drug effectiveness and adverse events. This program will support the Ministry of Health in Malawi to deliver on its priorities as set out in the national strategic plans for health and diagnostics. The new National HIV Treatment guidelines have adopted raising the CD4 cut-off to 500 and suggest use of viral load for treatment monitoring. Through PEPFAR, CDC-Malawi has funded capacity building collaborative agreements in Malawi since 2002. Currently, PEPFAR has assisted in pre-service curriculum development; in-service training for HIV testing, CD4 count, viral load and early infant diagnosis; and biosafety and quality management systems implementation. PEPFAR has improved quality testing through the introduction of Strengthening Laboratory Management towards Accreditation (SLMTA) in at least 42 referral, central, and district laboratories. PEPFAR has built capacity for the national reference laboratory to develop quarterly dry tube test proficiency testing and quality control specimens. Some laboratories have also been enrolled on external quality assurance programs for HIV PCR, chemistry, hematology, and Gene Xpert. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Priyanka Rathod
wnv9@cdc.gov Email:wnv9@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 286889 Full Announcement-Full Announcement -> Malawi CDC-RFA-GH15-15510201SUPP16.pdf
Packages
| Agency Contact Information: | Priyanka Rathod wnv9@cdc.gov Email: wnv9@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.067 | CDC-RFA-GH15-15510201SUPP16 | Program Expansion Supplement: Strengthening High Quality Laboratory Services Scale-up for HIV Diagnosis, Care, Treatment and Monitoring in Malawi under the President’s Emergency Plan for AIDS Relief (PEPFAR) | PKG00226312 | Aug 02, 2016 | Oct 01, 2016 | View |
Package 1
Mandatory forms
286889 SF424_2_1-2.1.pdf
286889 SF424A-1.0.pdf
286889 BudgetNarrativeAttachments_1_2-1.2.pdf
286889 ProjectNarrativeAttachments_1_2-1.2.pdf
286889 SF424D-1.1.pdf
286889 SF424B-1.1.pdf
Optional forms
286889 OtherNarrativeAttachments_1_2-1.2.pdf